Alderys SAS
Nutrients through rectified biosynthetic routes.
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenues | 3.0m | 2.5m | 1.9m | 3.0m | 3.1m | 5.2m | 2.7m |
| % growth | - | (17 %) | (25 %) | 61 % | 3 % | 66 % | (47 %) |
| EBITDA | <1m | (<1m) | (<1m) | <1m | <1m | 2.4m | (<1m) |
| % EBITDA margin | 18 % | - | (30 %) | 9 % | 16 % | 46 % | (1 %) |
| Profit | 1.1m | <1m | (<1m) | <1m | 1.1m | 2.5m | <1m |
| % profit margin | 36 % | 24 % | - | 26 % | 36 % | 48 % | 24 % |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Acquisition | ||
| Total Funding | - | ||